Annual Report 1996–97

1. Amendola, A., Gougeon, M.-L., Poccia, F., Fésüs, L. and Piacentini, M.: Tissue transglutaminaseindicates high rate of apoptosis in the immune system of HIV-infected individuals. Proceedings of theNational Academy of Sciences, U.S.A., 93, 11057-11062, 1996.2. Bagossi, P., Cheng, Y.-S.E., Oroszlan, S. and Tôzsér, J.: Activity of linked HIV-1 proteinasedimers containing mutations in the active site region. Protein Engineering 9, 997-1003, 1996.3. Balajthy, Z., Kedei, N., Nagy, L., Davies, P.J.A. and Fésüs, L.: Lack of induction of tissuetransglutaminase but activation of the preexisting enzyme in c-myc-induced apoptosis of CHO cells.Biochemical and Biophysical Research Communications 236, 280-284, 1997.4. Hua, Y.Z., Noonan, S., Nagy, L., Davies, P.J.A. and Stein, J.P.: Retinoic acid induction of thetissue transglutaminase promoter is mediated by a novel response element. Molecular and CellularEndocrinology 120, 203-212, 1996.5. Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L. andRonald M. Evans: Nuclear receptor repression mediated by a complex containing SMRT, mSin3A andhistone deacetylase. Cell 89, 373-380, 1997.6. Mádi, A., Punyiczki, M. and Fésüs, L.: Lessons to learn from the cell death and heat shockgenes of Caenorhabditis elegans. Acta Biologica Hungarica 48, 303-318, 1997.7. Nagy, L., Thomázy, V.A., Saydak, M.M., Stein, J.P. and Davies, P.J.A.: The promoter of the mousetissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linkedexpression.Cell Death and Differentiation 4, 534-547, 1997.8. Nemes, Z., Ådány, R., Balázs, M., Boross, P. and Fésüs, L.: Identification of cytoplasmic actinas an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoingapoptosis. The Journal of Biological Chemistry 272, 20577-20583, 1997.9. Oliverio, S., Amendola, A., di Sano, F., Farrace, M.G., Fesus, L., Nemes, L., Piredda, L., Spinedi,A. and Piacentini, M.: Tissue transglutaminase-dependent posttranslational modification of theretinoblastoma gene product in promonocytic cells undergoing apoptosis. Molecular and CellularBiology 17, 6040-6048, 1997.10. Piredda, L., Amendola, A., Colizzi, V., Davies, P.J.A., Farrace, M.G., Fraziano, M., Gentile, V.,Uray, I., Piacentini, M. and Fesus, L.: Lack of 'tissue' transglutaminase protein cross-linking leads toleakage of macromolecules from dying cells: relationship to development of autoimmunity inMRLlpr/lpr mice. Cell Death and Differentiation 4, 463-472, 1997.11. Schittny, J.C., Paulsson, M., Vallan, C., Burri, P.H., Kedei, N. and Aeschlimann, D.: Protein crosslinkingmediated by tissue transglutaminase correlates with the maturation of extracellular matricesduring lung development. Am. J. Respir. Cell Mol. Biol. 17, 334-343, 1997.12. Szondy, Z., Molnár, P., Nemes, Z., Boyiadzis, M., Kedei, N., Tóth, R. and Fésüs, L.:Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced viadistinct signalling pathways. FEBS Letters 404, 307-313, 1997.13. Szondy, Z., Reichert, U., Bernardoon, J.M., Michel, S., Tóth, R., Lecoeur, H., Gougeon, M.-L.and Fésüs, L.: Retinoic acids differentially modulate various forms of T cell death. Cell Biol. Int. 20,231-232, 1996.14. Szondy, Z., Reichert, U., Bernardoon, J.M., Michel, S., Tóth, R., Ancienne, P. and Fésüs, L.:Induction of apoptosis by retinoids and RARt selective compounds in mouse thymocytes through anovel apoptosis pathway. Mol. Pharmacol. 51, 972-982, 1997.15. Szondy, Z.: Methylprednisolone and 2-chloroadenosine induce DNA fragmentation at differentstages of human T lymphocyte development. Immunol. Lett. 58, 59-62, 1997.